Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 28, 2019 14:00 ET | Source: Rigrodsky & Long, P.A.

THOR, ARQL, TIF, and AMTD SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

WILMINGTON, Del., Dec. 28, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Synthorx, Inc. (NASDAQ GS: THOR) regarding possible breaches of fiduciary duties...
July 20, 2016 07:00 ET | Source: ArQule, Inc.

ArQule To Report Second Quarter 2016 Financial Results On August 3, 2016

BURLINGTON, Mass., July 20, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (Nasdaq:ARQL) today announced it will report financial results for the second quarter 2016 before the market opens on Wednesday,...
July 05, 2016 07:00 ET | Source: ArQule, Inc.

ArQule to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 12, 2016

BURLINGTON, Mass., July 05, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (Nasdaq:ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of...
June 30, 2016 07:00 ET | Source: ArQule, Inc.

ArQule Presents Preliminary Clinical Data for ARQ 087 Demonstrating Evidence of Anticancer Activity in Intrahepatic Cholangiocarcinoma at the ESMO 18th World Congress on Gastrointestinal Cancer

75% disease control rate, including a 25% objective response rate, was observed in 12 evaluable patients harboring FGFR2 genetic alterations BURLINGTON, Mass., June 30, 2016 (GLOBE NEWSWIRE) --...
April 20, 2016 07:30 ET | Source: ArQule, Inc.

ArQule To Report First Quarter 2016 Financial Results On May 4, 2016

BURLINGTON, Mass., April 20, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (Nasdaq:ARQL) today announced it will report financial results for the first quarter 2016 before the market opens on Wednesday, May...
April 05, 2016 07:30 ET | Source: ArQule, Inc.

ArQule to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016

BURLINGTON, Mass., April 05, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (Nasdaq:ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of...
February 29, 2016 06:55 ET | Source: ArQule, Inc.

ArQule Announces $15.3 Million Registered Direct Offering of Common Stock

BURLINGTON, Mass., Feb. 29, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (NASDAQ:ARQL) today announced it has entered into definitive agreements with certain institutional and accredited investors to raise...
February 15, 2016 07:30 ET | Source: ArQule, Inc.

ArQule to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016

BURLINGTON, Mass., Feb. 15, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (NASDAQ:ARQL) today announced it will report financial results for the fourth quarter and full year 2015 before the market opens on...
February 04, 2016 07:30 ET | Source: ArQule, Inc.

ArQule to Present at Upcoming Investor Conferences

BURLINGTON, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (NASDAQ:ARQL) today announced that Paolo Pucci, Chief Executive Officer and Dr. Brian Schwartz, Chief Medical Officer and Head of...
January 25, 2016 07:30 ET | Source: ArQule, Inc.

ArQule Presents Clinical Biomarker Data From Phase 2 Study and Ongoing Phase 3 METIV-HCC Study of Tivantinib in Second-Line Hepatocellular Carcinoma at the 2016 Gastrointestinal Cancers Symposium

Preliminary analysis of baseline MET incidence in METIV-HCC trial confirms results observed in phase 2 trial BURLINGTON, Mass., Jan. 25, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (NASDAQ:ARQL)...

Next Page keyboard_arrow_right